Other
Proceeds from disposition of marketable securities and other investments
Medtronic Proceeds from disposition of marketable securities and other investments decreased by 10.3% to $2.01B in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 6.8%, from $2.16B to $2.01B. Over 4 years (FY 2021 to FY 2025), Proceeds from disposition of marketable securities and other investments shows a downward trend with a -7.0% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ1 2026Aug 26, 2025
How to read this metric
High proceeds indicate the conversion of financial assets into cash, often to fund operations or acquisitions.
Detailed definition
Cash inflows generated from the sale, maturity, or collection of financial investments and marketable securities. This r...
Peer comparison
Standard for companies managing large investment portfolios.
Metric ID:
other_proceeds_from_sale_maturity_and_collections_of_inv_6d369eHistorical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.59B | $2.32B | $1.29B | $3.52B | $2.56B | $1.89B | $1.45B | $2.05B | $1.96B | $1.75B | $2.59B | $804.00M | $2.30B | $2.16B | $1.80B | $2.30B | $2.24B | $2.01B |
| QoQ Change | — | -49.4% | -44.7% | +174.0% | -27.2% | -26.4% | -23.1% | +41.4% | -4.6% | -10.6% | +48.2% | -69.0% | +185.9% | -6.2% | -16.5% | +27.5% | -2.5% | -10.3% |
| YoY Change | — | — | — | — | -44.2% | -18.8% | +12.8% | -41.7% | -23.7% | -7.3% | +78.6% | -60.8% | +17.5% | +23.4% | -30.5% | +185.7% | -2.6% | -6.8% |
Range$804.00M – $4.59B
CAGR-17.7%
Avg YoY Growth+5.8%
Median YoY Growth-7.1%
Current Streak2 quarters decline
Proceeds from disposition of marketable securities and other investments at Other Companies
Frequently Asked Questions
- What is Medtronic's proceeds from disposition of marketable securities and other investments?
- Medtronic (MDT) reported proceeds from disposition of marketable securities and other investments of $2.01B in Q2 2025.
- How has Medtronic's proceeds from disposition of marketable securities and other investments changed year-over-year?
- Medtronic's proceeds from disposition of marketable securities and other investments decreased by 6.8% year-over-year, from $2.16B to $2.01B.
- What is the long-term trend for Medtronic's proceeds from disposition of marketable securities and other investments?
- Over 4 years (2021 to 2025), Medtronic's proceeds from disposition of marketable securities and other investments has grown at a -7.0% compound annual growth rate (CAGR), from $11.35B to $8.50B.
- What does proceeds from disposition of marketable securities and other investments mean?
- Cash received from selling or maturing financial investments.